Christian Volmar Skovsgaard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Christian Volmar Skovsgaard has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Kim Rose Olsen
Danish Centre for Health Economics, University of Southern Denmark, Odense, Denmark
6 shared publications - Jan Hartvigsen
Centre for Muscle and Joint Health, Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark
5 shared publications - Amalie Wiben
University of Southern DaCHE – Danish Centre for Health Economics
3 shared publications - Karen Søgaard
Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, 5230 Odense, Denmark
3 shared publications - Stine Clausen
Center for Muscle and Joint Health, Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark
3 shared publications - Troels Kristensen
University of Southern Denmark, Department of Public Health, Odense, Denmark
3 shared publications
Latest Publications
- Open Access
- 18 November 2026
- Published by Oxford University Press (OUP) in Rheumatology
Cost-Effectiveness of Digital Patient Education in Rheumatoid Arthritis: An economic evaluation from a randomised controlled trial
Objective: Self-management support is essential in rheumatoid arthritis (RA). The WebRA trial showed that digital patient education (PE) improves self-efficacy, supports self-management, and reduces outpatient visits. This study assessed the 12-month cost-effectiveness from a partial societal perspective. Methods: Adults newly diagnosed with RA were randomised to digital or face-to-face PE. Quality-adjusted life years (QALYs) were estimated from EQ-5D-5L measurements over 12 months. Costs were obtained from national registries and incremental cost-effectiveness ratios (ICERs) were calculated. The probability of cost-effectiveness was estimated using probabilistic sensitivity analysis. Minimal important change in self-efficacy was the secondary outcome. Results: Baseline characteristics of the 175 participants were balanced (intervention vs control): 60.7% vs 61.5% female, mean age 58 vs 56 years, and mean disease activity score (DAS28) 4.4 vs 4.6. Digital PE led to lower healthcare costs (€9,322 vs €9,886), and minor QALY gains (mean difference 0.013). The intervention was dominant in both adjusted and crude models, with ICERs of -€43,692/QALY and -€24,056/QALY, respectively. In bootstrap analyses, 47.3% (adjusted) and 52.7% (crude) of iterations fell in the south-east quadrant (lower costs, better outcomes). Probability of cost-effectiveness reached 71.5% at a €22,665/QALY threshold. For self-efficacy, digital PE was cost-saving, but effects were small and inconsistent. Conclusions: Digital PE was associated with lower costs and a small QALY gain compared with face-to-face PE, with a moderate probability of cost-effectiveness. Digital PE may be a cost-effective alternative; however, the estimated effects were subject to some uncertainty and sensitivity to model specification. Further investigation in broader populations is warranted.
- 18 November 2026
- Published by Oxford University Press (OUP) in Rheumatology
Open AccessCost-Effectiveness of Digital Patient Education in Rheumatoid Arthritis: An economic evaluation from a randomised controlled trial
Objective: Self-management support is essential in rheumatoid arthritis (RA). The WebRA trial showed that digital patient education (PE) improves self-efficacy, supports self-management, and reduces outpatient visits. This study assessed the 12-month cost-effectiveness from a partial societal perspective. Methods: Adults newly diagnosed with RA were randomised to digital or face-to-face PE. Quality-adjusted life years (QALYs) were estimated from EQ-5D-5L measurements over 12 months. Costs were obtained from national registries and incremental cost-effectiveness ratios (ICERs) were calculated. The probability of cost-effectiveness was estimated using probabilistic sensitivity analysis. Minimal important change in self-efficacy was the secondary outcome. Results: Baseline characteristics of the 175 participants were balanced (intervention vs control): 60.7% vs 61.5% female, mean age 58 vs 56 years, and mean disease activity score (DAS28) 4.4 vs 4.6. Digital PE led to lower healthcare costs (€9,322 vs €9,886), and minor QALY gains (mean difference 0.013). The intervention was dominant in both adjusted and crude models, with ICERs of -€43,692/QALY and -€24,056/QALY, respectively. In bootstrap analyses, 47.3% (adjusted) and 52.7% (crude) of iterations fell in the south-east quadrant (lower costs, better outcomes). Probability of cost-effectiveness reached 71.5% at a €22,665/QALY threshold. For self-efficacy, digital PE was cost-saving, but effects were small and inconsistent. Conclusions: Digital PE was associated with lower costs and a small QALY gain compared with face-to-face PE, with a moderate probability of cost-effectiveness. Digital PE may be a cost-effective alternative; however, the estimated effects were subject to some uncertainty and sensitivity to model specification. Further investigation in broader populations is warranted.
- Open Access
- 9 August 2026
- Published by Elsevier in Social Science & Medicine
- Vol. 407
Early career health shocks and long-run labour market outcomes
- 9 August 2026
- Published by Elsevier in Social Science & Medicine
- Vol. 407
Open AccessEarly career health shocks and long-run labour market outcomes
- Open Access
- 24 May 2026
- Published by Wiley in European journal of pain
- Vol. 30 (6) , e70305
Changes in Gabapentinoid Use Among Danish Patients With Spinal Pain: A Comparison of Two Secondary Care Cohorts 2013–2014 and 2021–2022
Background: Gabapentinoids (gabapentin and pregabalin) are increasingly prescribed for spinal pain despite limited evidence of benefit and recognised risks. Understanding which characteristics influence prescribing and how prescription use has evolved may inform safer and more evidence‐based practice. Objectives: To compare determinants of gabapentinoid use and changes over time between two separate cohorts of patients referred to the Spine Centre of Southern Denmark. Methods: Our study comprised two cohorts: the first, from 2013 to 2014 ( n = 16,732), and the second, from 2021 to 2022 ( n = 13,939). Redeemed gabapentinoid prescriptions were assessed within a 12‐month window (6 months before and after the spine centre index date) and linked with diagnostic, socioeconomic and patient‐reported information. Patients were categorised as continued users, initiators, discontinuers or non‐users using a ≥ 30 defined daily dose classification threshold to distinguish sporadic from more sustained dispensing. Multinomial logistic regression, incorporating demographic, socioeconomic and clinical covariates, identified characteristics associated with use. Results: Gabapentinoid use more than doubled from Cohort 1 to Cohort 2, with continued users increasing from 2.4% to 6.6% and initiators increasing from 3.5% to 6.1%. Radiculopathy, higher disability and concurrent opioid or weak analgesic use showed the strongest positive associations with use across both cohorts. Conclusions: Gabapentinoid use for patients with spinal pain attending secondary care in Denmark increased substantially across the decade, despite only modest differences in patient characteristics. Gabapentinoid use remained concentrated among patients with radiculopathy and concurrent analgesic use, underscoring continued reliance on pharmacological management. Significance Statement: This study identifies a marked rise in gabapentinoid prescribing for spinal pain in secondary care and shows that the increase was only partly explained by differences in patient characteristics. The findings highlight continued use in patient groups where clinical benefit remains unproven, reinforcing the need for safer, more evidence‐based prescribing strategies.
- 24 May 2026
- Published by Wiley in European journal of pain
- Vol. 30 (6) , e70305
Open AccessChanges in Gabapentinoid Use Among Danish Patients With Spinal Pain: A Comparison of Two Secondary Care Cohorts 2013–2014 and 2021–2022
Background: Gabapentinoids (gabapentin and pregabalin) are increasingly prescribed for spinal pain despite limited evidence of benefit and recognised risks. Understanding which characteristics influence prescribing and how prescription use has evolved may inform safer and more evidence‐based practice. Objectives: To compare determinants of gabapentinoid use and changes over time between two separate cohorts of patients referred to the Spine Centre of Southern Denmark. Methods: Our study comprised two cohorts: the first, from 2013 to 2014 ( n = 16,732), and the second, from 2021 to 2022 ( n = 13,939). Redeemed gabapentinoid prescriptions were assessed within a 12‐month window (6 months before and after the spine centre index date) and linked with diagnostic, socioeconomic and patient‐reported information. Patients were categorised as continued users, initiators, discontinuers or non‐users using a ≥ 30 defined daily dose classification threshold to distinguish sporadic from more sustained dispensing. Multinomial logistic regression, incorporating demographic, socioeconomic and clinical covariates, identified characteristics associated with use. Results: Gabapentinoid use more than doubled from Cohort 1 to Cohort 2, with continued users increasing from 2.4% to 6.6% and initiators increasing from 3.5% to 6.1%. Radiculopathy, higher disability and concurrent opioid or weak analgesic use showed the strongest positive associations with use across both cohorts. Conclusions: Gabapentinoid use for patients with spinal pain attending secondary care in Denmark increased substantially across the decade, despite only modest differences in patient characteristics. Gabapentinoid use remained concentrated among patients with radiculopathy and concurrent analgesic use, underscoring continued reliance on pharmacological management. Significance Statement: This study identifies a marked rise in gabapentinoid prescribing for spinal pain in secondary care and shows that the increase was only partly explained by differences in patient characteristics. The findings highlight continued use in patient groups where clinical benefit remains unproven, reinforcing the need for safer, more evidence‐based prescribing strategies.
- Open Access
- 14 April 2026
- Published by Springer Nature in Chiropractic & Manual Therapies
- Vol. 34 (1)
Use of prescribed analgesics before and after a standardised chiropractic care programme among patients with lumbar spinal stenosis: a nationwide cohort study
Background: Patients with degenerative lumbar spinal stenosis (LSS) commonly use analgesics despite not being recommended by clinical guidelines. However, detailed knowledge of utilisation patterns is limited. This study aimed to describe prescribed analgesic use before, during, and after enrolment in a standardised chiropractic care programme, and to examine associations between patient characteristics and continued analgesic use after the programme. Methods: This cohort study included patients with LSS enrolled in the chiropractic care programme between 1 April 2017 and 31 December 2022, identified via the Danish National Health Service Register. The programme provides guideline-based non-pharmacological care, structured follow-up, and coordination with the patient's general practitioner. Data on dispensed analgesics were retrieved from the Danish National Prescription Registry. Quarterly prevalence of analgesic use (≥ 1 dispensed prescriptions) and defined daily doses per 1000 individuals were calculated for the year before enrolment, 3 months during, and the year after the programme. The distribution of use was assessed using Lorenz curves and Gini coefficients. Associations between patient characteristics and continued analgesic use (≥ 1 dispensed prescriptions in ≥ 2 of 4 consecutive quarters) after the programme among existing users were examined using robust Poisson regression. Results: Of the 7294 included patients, 45% used analgesics in the year before enrolment. Use of paracetamol, non-steroidal anti-inflammatory drugs (NSAID), opioids, and gabapentinoids increased in the year before enrolment, peaked during the programme, and generally declined after. Ten percent of analgesic users accounted for approximately 43%, 49%, 68%, and 57% of the total use of paracetamol, NSAIDs, opioids, and gabapentinoids, respectively. Female sex, having one comorbidity, and pre-existing use of paracetamol, opioid, or gabapentinoid were associated with a 5–16% higher risk of continued use, whereas long-cycle higher education was associated with a 13% lower risk. Conclusions: Analgesic use increased before enrolment, peaked during the programme, and then declined after. A small proportion of analgesic users accounted for a large share of the total use. Sociodemographic and health-related factors, and pre-existing analgesic use were associated with continued use. These findings highlight the complexity of analgesic use in this population and emphasise the need for deprescribing strategies that take this complexity into account.
- 14 April 2026
- Published by Springer Nature in Chiropractic & Manual Therapies
- Vol. 34 (1)
Open AccessUse of prescribed analgesics before and after a standardised chiropractic care programme among patients with lumbar spinal stenosis: a nationwide cohort study
Background: Patients with degenerative lumbar spinal stenosis (LSS) commonly use analgesics despite not being recommended by clinical guidelines. However, detailed knowledge of utilisation patterns is limited. This study aimed to describe prescribed analgesic use before, during, and after enrolment in a standardised chiropractic care programme, and to examine associations between patient characteristics and continued analgesic use after the programme. Methods: This cohort study included patients with LSS enrolled in the chiropractic care programme between 1 April 2017 and 31 December 2022, identified via the Danish National Health Service Register. The programme provides guideline-based non-pharmacological care, structured follow-up, and coordination with the patient's general practitioner. Data on dispensed analgesics were retrieved from the Danish National Prescription Registry. Quarterly prevalence of analgesic use (≥ 1 dispensed prescriptions) and defined daily doses per 1000 individuals were calculated for the year before enrolment, 3 months during, and the year after the programme. The distribution of use was assessed using Lorenz curves and Gini coefficients. Associations between patient characteristics and continued analgesic use (≥ 1 dispensed prescriptions in ≥ 2 of 4 consecutive quarters) after the programme among existing users were examined using robust Poisson regression. Results: Of the 7294 included patients, 45% used analgesics in the year before enrolment. Use of paracetamol, non-steroidal anti-inflammatory drugs (NSAID), opioids, and gabapentinoids increased in the year before enrolment, peaked during the programme, and generally declined after. Ten percent of analgesic users accounted for approximately 43%, 49%, 68%, and 57% of the total use of paracetamol, NSAIDs, opioids, and gabapentinoids, respectively. Female sex, having one comorbidity, and pre-existing use of paracetamol, opioid, or gabapentinoid were associated with a 5–16% higher risk of continued use, whereas long-cycle higher education was associated with a 13% lower risk. Conclusions: Analgesic use increased before enrolment, peaked during the programme, and then declined after. A small proportion of analgesic users accounted for a large share of the total use. Sociodemographic and health-related factors, and pre-existing analgesic use were associated with continued use. These findings highlight the complexity of analgesic use in this population and emphasise the need for deprescribing strategies that take this complexity into account.
- Open Access
- 16 January 2026
- Published by Wolters Kluwer Health in Pain Reports
- Vol. 11 (1)
Predicting high health care use in patients with spinal disorder in secondary care: model development and validation
Introduction: Spinal disorders are among the biggest contributors to health care utilization (HCU). Objective: To develop and externally validate a prediction model for high all-cause HCU (75th percentile during 1 year after the index date) among patients with spinal disorders visiting multidisciplinary secondary care clinics. Methods: We developed and internally validated the model using the Norwegian Neck and Back Registry, including patients registered between January 1, 2016, and December 31, 2020, linked with national health registries (N = 9092). For external validation, we used data from the Danish SpineData Registry, linked with national registries, for the same period (N = 34,853). We assessed Nagelkerke R 2 , discrimination (area under receiver operating characteristics curve [AUC]), and calibration (calibration-in-the-large [CITL], slope, and calibration plot). Results: The final model included sex, nationality, education, physical activity, smoking, prior HCU, work status, disability, health-related quality of life, medicine use, diagnosis, kinesiophobia, and comorbidity. It demonstrated acceptable discrimination (AUC 0.78, 95% confidence interval [CI], 0.77–0.78), an R 2 of 0.26, and good calibration after internal validation. Upon external validation, the model demonstrated excellent discrimination (AUC 0.81, 95% CI 0.80–0.81) and an R 2 of 0.31. The calibration slope was 1.08 (95% CI 1.06–1.11) and CITL was 0.16 (95% CI 0.12–0.19). Predicted probabilities closely matched observed probabilities across all deciles in internal validation, with slight underestimation of high HCU in the top 3 deciles during external validation. Conclusion: Overall, the model shows promise in predicting high HCU in patients with spinal disorders referred to secondary care but requires further testing and validation in implementation settings before recommendation.
- 16 January 2026
- Published by Wolters Kluwer Health in Pain Reports
- Vol. 11 (1)
Open AccessPredicting high health care use in patients with spinal disorder in secondary care: model development and validation
Introduction: Spinal disorders are among the biggest contributors to health care utilization (HCU). Objective: To develop and externally validate a prediction model for high all-cause HCU (75th percentile during 1 year after the index date) among patients with spinal disorders visiting multidisciplinary secondary care clinics. Methods: We developed and internally validated the model using the Norwegian Neck and Back Registry, including patients registered between January 1, 2016, and December 31, 2020, linked with national health registries (N = 9092). For external validation, we used data from the Danish SpineData Registry, linked with national registries, for the same period (N = 34,853). We assessed Nagelkerke R 2 , discrimination (area under receiver operating characteristics curve [AUC]), and calibration (calibration-in-the-large [CITL], slope, and calibration plot). Results: The final model included sex, nationality, education, physical activity, smoking, prior HCU, work status, disability, health-related quality of life, medicine use, diagnosis, kinesiophobia, and comorbidity. It demonstrated acceptable discrimination (AUC 0.78, 95% confidence interval [CI], 0.77–0.78), an R 2 of 0.26, and good calibration after internal validation. Upon external validation, the model demonstrated excellent discrimination (AUC 0.81, 95% CI 0.80–0.81) and an R 2 of 0.31. The calibration slope was 1.08 (95% CI 1.06–1.11) and CITL was 0.16 (95% CI 0.12–0.19). Predicted probabilities closely matched observed probabilities across all deciles in internal validation, with slight underestimation of high HCU in the top 3 deciles during external validation. Conclusion: Overall, the model shows promise in predicting high HCU in patients with spinal disorders referred to secondary care but requires further testing and validation in implementation settings before recommendation.
- Open Access
- 8 October 2025
- Published by Elsevier in Journal of Development Economics
- Vol. 179
Holy cows and spilled milk: The impact of religious missions on firm-level productivity
- 8 October 2025
- Published by Elsevier in Journal of Development Economics
- Vol. 179
Open AccessHoly cows and spilled milk: The impact of religious missions on firm-level productivity
- Open Access
Cost-effectiveness analysis of app-delivered self-management support (selfBACK) in addition to usual care for people with low back pain in Denmark
Objectives This study aims to investigate the cost-effectiveness of individually tailored self-management support, delivered via the artificial intelligence-based selfBACK app, as an add-on to usual care for people with low back pain (LBP). Design Secondary health-economic analysis of the selfBACK randomised controlled trial (RCT) with a 9-month follow-up conducted from a Danish national healthcare perspective (primary scenario) and a societal perspective limited to long-term productivity in the form of long-term absenteeism (secondary scenario). Setting Primary care and an outpatient spine clinic in Denmark. Participants A subset of Danish participants in the selfBACK RCT, including 297 adults with LBP randomised to the intervention (n=148) or the control group (n=149). Interventions App-delivered evidence-based, individually tailored self-management support as an add-on to usual care compared with usual care alone among people with LBP. Outcome measures Costs of healthcare usage and productivity loss, quality-adjusted life-years (QALYs) based on the EuroQol-5L Dimension Questionnaire, meaningful changes in LBP-related disability measured by the Roland-Morris Disability Questionnaire (RMDQ) and the Pain Self-Efficacy Questionnaire (PSEQ), costs (healthcare and productivity loss measured in Euro) and incremental cost-effectiveness ratios (ICERs). Results The incremental costs were higher for the selfBACK intervention (mean difference €230 (95% CI −136 to 595)), where ICERs showed an increase in costs of €7336 per QALY gained in the intervention group, and €1302 and €1634 for an additional person with minimal important change on the PSEQ and RMDQ score, respectively. At a cost-effectiveness threshold value of €23250, the selfBACK intervention has a 98% probability of being cost-effective. Analysis of productivity loss was very sensitive, which creates uncertainty about the results from a societal perspective limited to long-term productivity. Conclusions From a healthcare perspective, the selfBACK intervention is likely to represent a cost-effective treatment for people with LBP. However, including productivity loss introduces uncertainty to the results. Trial registration number NCT03798288.
Open AccessCost-effectiveness analysis of app-delivered self-management support (selfBACK) in addition to usual care for people with low back pain in Denmark
Objectives This study aims to investigate the cost-effectiveness of individually tailored self-management support, delivered via the artificial intelligence-based selfBACK app, as an add-on to usual care for people with low back pain (LBP). Design Secondary health-economic analysis of the selfBACK randomised controlled trial (RCT) with a 9-month follow-up conducted from a Danish national healthcare perspective (primary scenario) and a societal perspective limited to long-term productivity in the form of long-term absenteeism (secondary scenario). Setting Primary care and an outpatient spine clinic in Denmark. Participants A subset of Danish participants in the selfBACK RCT, including 297 adults with LBP randomised to the intervention (n=148) or the control group (n=149). Interventions App-delivered evidence-based, individually tailored self-management support as an add-on to usual care compared with usual care alone among people with LBP. Outcome measures Costs of healthcare usage and productivity loss, quality-adjusted life-years (QALYs) based on the EuroQol-5L Dimension Questionnaire, meaningful changes in LBP-related disability measured by the Roland-Morris Disability Questionnaire (RMDQ) and the Pain Self-Efficacy Questionnaire (PSEQ), costs (healthcare and productivity loss measured in Euro) and incremental cost-effectiveness ratios (ICERs). Results The incremental costs were higher for the selfBACK intervention (mean difference €230 (95% CI −136 to 595)), where ICERs showed an increase in costs of €7336 per QALY gained in the intervention group, and €1302 and €1634 for an additional person with minimal important change on the PSEQ and RMDQ score, respectively. At a cost-effectiveness threshold value of €23250, the selfBACK intervention has a 98% probability of being cost-effective. Analysis of productivity loss was very sensitive, which creates uncertainty about the results from a societal perspective limited to long-term productivity. Conclusions From a healthcare perspective, the selfBACK intervention is likely to represent a cost-effective treatment for people with LBP. However, including productivity loss introduces uncertainty to the results. Trial registration number NCT03798288.
- Open Access
- 26 March 2024
- Published by Springer Nature in European Spine Journal
- Vol. 33 (6) , 2395-2404
Tip of the iceberg: unveiling the impact on back disorders from cumulative physical job exposure and evaluating bias from the healthy worker effect using a nationwide longitudinal cohort study
Purpose: Longitudinal studies across various sectors with physically demanding jobs are notably absent in back disorder risk research. This study aimed to investigate the relationship between cumulative physical job exposure (PJE) and hospital-diagnosed back disorders among individuals in Denmark. To assess the healthy worker effect, we compared the cumulative risk estimate with results from a naive cross-sectional model ignoring PJE history. Methods: A nationwide longitudinal cohort study was conducted using Danish registers, encompassing individuals born between 1975 and 1978 and working in 1996. Cumulative PJE was measured with a 10-year look-back period for each year 2006–2017. PJE consisted of lower-body occupational exposures, including the total weight lifted, stand/sit ratio, and the frequency of lifting more than 20 kg per day from a job exposure matrix. Odds ratio for back disorders was estimated for each year and all years combined. Results: The results unveiled a significant 31% increase in the risk of hospital-diagnosed back disorders after 4 years of cumulative PJE. The lowest risk (7%) was observed for incident back disorders with 1 year of exposure, suggesting a healthy worker effect. Nevertheless, this risk is still significantly elevated. This cumulative estimate is fourfold the estimate from the 2006 naive cross section model. Conclusion: Our study clearly demonstrates an 31% increase in the risk of hospital-diagnosed back disorders with just 4 years of PJE over a 10-year period. Further, we find that cross-sectional studies strongly underestimate the risk of back disorders due to the healthy worker effect.
- 26 March 2024
- Published by Springer Nature in European Spine Journal
- Vol. 33 (6) , 2395-2404
Open AccessTip of the iceberg: unveiling the impact on back disorders from cumulative physical job exposure and evaluating bias from the healthy worker effect using a nationwide longitudinal cohort study
Purpose: Longitudinal studies across various sectors with physically demanding jobs are notably absent in back disorder risk research. This study aimed to investigate the relationship between cumulative physical job exposure (PJE) and hospital-diagnosed back disorders among individuals in Denmark. To assess the healthy worker effect, we compared the cumulative risk estimate with results from a naive cross-sectional model ignoring PJE history. Methods: A nationwide longitudinal cohort study was conducted using Danish registers, encompassing individuals born between 1975 and 1978 and working in 1996. Cumulative PJE was measured with a 10-year look-back period for each year 2006–2017. PJE consisted of lower-body occupational exposures, including the total weight lifted, stand/sit ratio, and the frequency of lifting more than 20 kg per day from a job exposure matrix. Odds ratio for back disorders was estimated for each year and all years combined. Results: The results unveiled a significant 31% increase in the risk of hospital-diagnosed back disorders after 4 years of cumulative PJE. The lowest risk (7%) was observed for incident back disorders with 1 year of exposure, suggesting a healthy worker effect. Nevertheless, this risk is still significantly elevated. This cumulative estimate is fourfold the estimate from the 2006 naive cross section model. Conclusion: Our study clearly demonstrates an 31% increase in the risk of hospital-diagnosed back disorders with just 4 years of PJE over a 10-year period. Further, we find that cross-sectional studies strongly underestimate the risk of back disorders due to the healthy worker effect.
- Open Access
- 18 July 2023
- Published by Wiley in Health Economics
- Vol. 32 (11) , 2477-2498
Increasing capitation in mixed remuneration schemes: Effects on service provision and process quality of care
Many health systems apply mixed remuneration schemes for general practitioners, but little is known about the effects on service provision of changing the relative mix of fee for services and capitation. We apply difference‐in‐differences analyses to evaluate a reform that effectively reversed the mix between fee for services and capitation from 80/20 to 20/80 for patients with type 2 diabetes. Our results show reductions in provision of both the contact services that became capitated and in other non‐capitated (still‐billable) services. Reduced provision also occurred for guideline‐recommended process quality services. We find that the effects are mainly driven by patients with co‐morbidities and by general practitioners with high income, relatively many diabetes patients, and solo practitioners. Thus, increasing capitation in a mixed remuneration schemes appears to reduce service provision for patients with type 2 diabetes monitored in general practice with a risk of unwanted quality effects.
- 18 July 2023
- Published by Wiley in Health Economics
- Vol. 32 (11) , 2477-2498
Open AccessIncreasing capitation in mixed remuneration schemes: Effects on service provision and process quality of care
Many health systems apply mixed remuneration schemes for general practitioners, but little is known about the effects on service provision of changing the relative mix of fee for services and capitation. We apply difference‐in‐differences analyses to evaluate a reform that effectively reversed the mix between fee for services and capitation from 80/20 to 20/80 for patients with type 2 diabetes. Our results show reductions in provision of both the contact services that became capitated and in other non‐capitated (still‐billable) services. Reduced provision also occurred for guideline‐recommended process quality services. We find that the effects are mainly driven by patients with co‐morbidities and by general practitioners with high income, relatively many diabetes patients, and solo practitioners. Thus, increasing capitation in a mixed remuneration schemes appears to reduce service provision for patients with type 2 diabetes monitored in general practice with a risk of unwanted quality effects.